Literature DB >> 5005311

Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species.

F M Collins.   

Abstract

Seven mycobacterial species were tested for their ability to immunize mice against subsequent tuberculous challenge. The phylogenetic relationships between the vaccine and challenge strains had little direct influence on the level of resistance; a better correlation was found between the ability of the vaccine to survive or multiply in vivo and the immunogenicity of the organism. Mycobacterium tuberculosis, M. bovis (except for an SM(R) variant), M. avium, two of three M. kansasii strains, and one strain of M. intracellulare all survived or multiplied in vivo. They induced an effective resistance against a subsequent M. tuberculosis (Erdman) or BCG challenge. The SM(R) BCG, the Bostrom strain of M. kansasii, M. scrofulaceum, three strains of M. intracellulare, and one of M. terrae and M. fortuitum were unable to survive in vivo and were nonallergenic and nonimmunogenic. No evidence was found for an interference phenomenon between the atypical mycobacteria and the BCG vaccine sufficient to explain the inadequate levels of immunization reported in some field trials.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5005311      PMCID: PMC416375          DOI: 10.1128/iai.4.6.688-696.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  The significance of the response of mice to immunization with viable unclassified mycobacteria.

Authors:  G P YOUMANS; R C PARLETT; A S YOUMANS
Journal:  Am Rev Respir Dis       Date:  1961-06

2.  Differential characteristics in vitro and in vivo of several substrains of BCG. III. Multiplication and survival in vivo.

Authors:  R J DUBOS; C H PIERCE; W B SCHAEFER
Journal:  Am Rev Tuberc       Date:  1956-11

Review 3.  Resistance to intracellular infection.

Authors:  G B Mackaness
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

4.  Immunity to Mycobacterium tuberculosis in mice. Effect of heterologous mycobacteria in relation to quantitative and qualitative differences in their organ localization.

Authors:  I Pejovic; F P Dunbar; R Cacciatore; H Valdez; E Sanders
Journal:  Am Rev Respir Dis       Date:  1969-05

5.  Tuberculosis studies in Muscogee County, Georgia. VII. A twenty-year evaluation of BCG vaccination in a school population.

Authors:  G W Comstock; R G Webster
Journal:  Am Rev Respir Dis       Date:  1969-12

6.  The relationship of delayed hypersensitivity to acquired antituberculous immunity. II. Effect of adjuvant on the allergenicity and immunogenicity of heat-killed tubercle bacilli.

Authors:  F M Collins; G B Mackaness
Journal:  Cell Immunol       Date:  1970-09       Impact factor: 4.868

Review 7.  Nonliving immunogenic substances of Mycobacteria.

Authors:  D W Smith; A A Grover; E Wiegeshaus
Journal:  Bibl Tuberc       Date:  1968

8.  Long-term results of BCG vaccination in the southern United States.

Authors:  G W Comstock; C E Palmer
Journal:  Am Rev Respir Dis       Date:  1966-02

9.  Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis.

Authors:  C E Palmer; M W Long
Journal:  Am Rev Respir Dis       Date:  1966-10

10.  Cross-protection against Salmonella enteritidis infection in mice.

Authors:  F M Collins
Journal:  J Bacteriol       Date:  1968-04       Impact factor: 3.490

View more
  20 in total

1.  Activation of mouse peritoneal macrophages by mannophosphoinositides of mycobacteria.

Authors:  P K Mehta; G K Khuller
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

2.  Cell mediated immunity cross-reactions of mycobacteria: polymorphism of target bacterial antigens.

Authors:  S Kulkarni; S Hattikudur; R S Kamat
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

Review 3.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

Review 4.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

5.  Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis.

Authors:  Lise Brandt; Joana Feino Cunha; Anja Weinreich Olsen; Ben Chilima; Penny Hirsch; Rui Appelberg; Peter Andersen
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.

Authors:  I M Orme; F M Collins
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

7.  Relative immunogenicity of streptomycin-sensitive and -resistant strains of BCG.

Authors:  F M Collins; V Montalbine
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

8.  Immunogenicity of living and heat-killed Salmonella pullorum vaccines.

Authors:  F M Collins
Journal:  Infect Immun       Date:  1973-05       Impact factor: 3.441

9.  Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.

Authors:  D Bourassa; A Forget; M Pelletier; E Skamene; R Turcotte
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

10.  Response of hypersensitive mice to the footpad injection of living homologous or heterologous mycobacteria: preliminary report.

Authors:  G P Kubica; F P Dunbar; T H Kim
Journal:  Appl Microbiol       Date:  1973-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.